Get started
Author

Paul Shaw

ORCID: 0009-0000-0797-9520
Observed ORCID: 0009-0000-0797-9520
OpenAlex ID: A5126963807
Project Optimus for Radiation Therapy–Drug Combinations: Moving Beyond the Maximum Tolerated Dose
2026 · Alastair Greystoke, Sarah Brown, et al. · International Journal of Radiation Oncology*Biology*Physics · 2
Ceralasertib plus Durvalumab in Ras Mutant and Ras Wild-Type Advanced Non–Small Cell Lung Cancer: Two Cohorts of the Phase II Platform National Lung Matrix Trial
2026 · Gary Middleton, Richard Buchanan, et al. · Clinical Cancer Research
Understanding pain in malignant mesothelioma: a prospective, longitudinal cohort study
2026 · Catriona R. Mayland, Michelle Collinson, et al. · BMC Palliative Care
205 A clinical practice guide to post-operative radiotherapy for Thymic Epithelial Tumours
2026 · Stephen Robinson, Pooja Bhatnagar, et al. · Lung Cancer
104 Hemi-thoracic irradiation with proton therapy in malignant pleural mesothelioma (HIT-Meso)
2026 · Crispin Hiley, Andrew Gosling, et al. · Lung Cancer
190 High dose palliative radiotherapy in NSCLC: a retrospective review of dose fractionation and outcomes
2026 · Sarah Walters, Gwenllian Edwards, et al. · Lung Cancer
Works count: 6
Citation count: 2
H-index: 1
I10-index:
Year
Topic
Type